EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
news

Worldwide Clinical Trials and Deep Lens Enter Strategic Alliance to Accelerate Recruitment and Development Timelines for Oncology Trials

MORRISVILLE, North Carolina, and COLUMBUS, Ohio – Worldwide Clinical Trials, Inc. (Worldwide), an award-winning, full-service, midsize, global CRO, and Deep Lens, an...
Continue Reading →
Europe

CRF Bracket Welcomes Susie Robinson as Chief People Officer

Strategic Senior Appointment Spearheads Compelling Work Culture for Continued Success LONDON, UK & PHILADELPHIA, PA – MARCH 07, 2019: CRF Bracket today an...
Continue Reading →
Europe

New treatment under trial could restore brain cells in Parkinson’s

A series of clinical trials have tested an experimental treatment for Parkinson's disease that uses a novel approach: administering the drug straight into the brain...
Continue Reading →
news

Could medical marijuana help grandma and grandpa with their ailments?

Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral s...
Continue Reading →
news

Second Vertex triple combo succeeds in cystic fibrosis, setting up crucial choice

An experimental triplet of drugs from Vertex Pharmaceuticals significantly improved lung function in people with cystic fibrosis across two Phase 3 studies, showing ...
Continue Reading →
Europe

Alnylam’s givosiran clears Phase 3 test in second RNAi win

Alnylam's experimental therapy for acute hepatic porphyria met its primary goal of reducing porphyria attacks versus placebo in a Phase 3 study, the company said Wed...
Continue Reading →
news

Novavax’s RSV vaccine fails second Phase III trial, further shrinking its pathways to success, says GlobalData

Following the news on 28 February 2019 that Novavax’s respiratory syncytial virus (RSV) disease vaccine for infants – ResVax – did not meet its primary Phase III en...
Continue Reading →
news

Nightstar acquisition will catapult Biogen in global ophthalmology market, says GlobalData

Following the news on 4th March 2019 that US-based biotechnology company, Biogen, has agreed to acquire London-based clinical-stage gene therapy company, Nightstar T...
Continue Reading →
news

Novartis moves forward on CV drug, paying $150M to Ionis, Akcea

Novartis said Monday it will exercise a licensing option on an experimental heart drug, paying $75 million to both Ionis Pharmaceuticals and Akcea Therapeutics as it...
Continue Reading →
news

Merck’s infant pneumococcal vaccine could threaten Pfizer’s longstanding market dominance, says GlobalData

Following the news that Merck & Co.’s V114 (15-valent pneumococcal conjugate vaccine) received FDA Breakthrough Therapy designation for the prevention of invasiv...
Continue Reading →
Quotient